Generate Biomedicines, Inc. Common Stock (GENB)

• Market cap: $1.57B
• 1 day: 4.15%
• 5 days: -7.66%
• 1 month: -2.77%
• 3 months: -2.77%
• 6 months: -2.77%
• Year to date: -2.77%
• 1 year: -2.77%
• 5 years: -2.77%
• 10 years: -2.77%
• Sector: Healthcare
• Industry: Biotechnology

About: Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.